Michael Scherer
@scherermich.bsky.social
430 followers 470 following 17 posts
Group leader in Computational Biology working on (single-cell) epigenomics and cancer @dkfz.bsky.social @[email protected] https://orcid.org/0000-0001-7990-6179
Posts Media Videos Starter Packs
Reposted by Michael Scherer
larsplus.bsky.social
This was a lot of fun! Thanks Daylon and @arunsharmaphd.bsky.social for being great hosts!
stemcellpodcast.com
We have a new episode out!

Dr. Lars Velten from the Centre for Genomic Regulation talks about his research on #LineageTracing and #hematopoiesis: https://bit.ly/4gsvo5X
Reposted by Michael Scherer
irbbarcelona.org
#IRBBarcelona⁩ & ⁨@crg.eu scientists identify DNA “barcodes” that mark blood cell #aging—accelerating after 50. Published in @nature.com, the work could pave the way for preventive, personalized #antiaging therapies.

https://youtu.be/ST5YmqqMcuQ

@alejofraticelli.bsky.social 

#AgingResearch

🧪
Enjoy the videos and music that you love, upload original content and share it all with friends, family and the world on YouTube.
youtu.be
Reposted by Michael Scherer
Reposted by Michael Scherer
simonhaas.bsky.social
Excited to share our latest paper @natmethods.nature.com
We present a high-throughput framework to map cellular interactions at ultra-high scale – broadly applicable from whole-organism immune response mapping to personalized therapy response prediction (1/4).
www.nature.com/articles/s41...
Reposted by Michael Scherer
biorxivpreprint.bsky.social
Integrative spatial and multi-omic profiling in bladder cancer links L1 retrotransposition to extrachromosomal DNA, genomic instability, and viral mimicry response https://www.biorxiv.org/content/10.1101/2025.07.30.667694v1
scherermich.bsky.social
Do you want to improve our understanding of therapy resistance induced by epigenetic heterogeneity? Do you have a PhD in Molecular Biology or related fields? Join us as a (fully-funded) Postdoc in the Division of Cancer Epigenomics at DKFZ. More information here: www.dkfz.de/en/cancer-ep...
Cancer Epigenomics - German Cancer Research Center
www.dkfz.de
scherermich.bsky.social
In our study published in Leukemia, we showed that HMA treatment can also lead to repression of oncogenes such as MNX1 through the activation of miRNAs. Great work by Simge Kelekci from our division. www.nature.com/articles/s41...
DNA demethylation-mediated downregulation of MNX1 in acute myeloid leukemia - Leukemia
Leukemia - DNA demethylation-mediated downregulation of MNX1 in acute myeloid leukemia
www.nature.com
scherermich.bsky.social
Out in Leukemia (@natureportfolio.nature.com). Hypomethylating agents (HMAs) such as decitabine are used in clinical practice for the treatment of Acute Myeloid Leukemia and expected to re-activate tumor suppressor genes de-activated by aberrant DNA methylation.
Reposted by Michael Scherer
dkfz.bsky.social
The next #ScienceatDKFZ event will take place on Monday, 23 June 2025, at 4 pm. In addition to the keynote lecture by Chong Sun, there will be four 5-minute short talks by DKFZ junior scientists on recent highlight publications.
➡️ dkfz.de/en/news/even...
Reposted by Michael Scherer
maxstammnitz.bsky.social
1 plant hormone receptor ☘️
3,500 mutants, to single-site saturation 🧬
>45,000 binding and abundance measurements 📶

Very happy to present our latest work – where deep mutational scanning meets the world of small molecules.



www.biorxiv.org/content/10.1...



With @benlehner.bsky.social

[1/7]
The genetic architecture of an allosteric hormone receptor
Many proteins function as switches, detecting chemicals and transducing their concentrations into cellular responses. Receptor switches are key to the integration of environmental signals, yet it is n...
www.biorxiv.org
Reposted by Michael Scherer
Reposted by Michael Scherer
dkfz.bsky.social
📢Die @dfg.de unterstützt in den kommenden vier Jahren den neuen Sonderforschungsbereich „Zelluläre Plastizität in malignen myeloischen Erkrankungen – Vom Mechanismus zur Therapie“ der Medizinischen Fakultät Heidelberg mit rund 15,8 Mio. Euro.
➡️ t1p.de/rpslw
15,8 Millionen Euro für neuen Sonderforschungsbereich zu Blutkrebs
Die Deutsche Forschungsgemeinschaft (DFG) unterstützt in den kommenden vier Jahren den neuen Sonderforschungsbereich (SFB) 1709 „Zelluläre Plastizität in malignen myeloischen Erkrankungen – Vom Mechan...
t1p.de
Reposted by Michael Scherer
flgenomics.bsky.social
The fantastic lineup for our latest webinar series, Unlocking the Epigenome: Precision Tools for Complex Diseases, includes: @chiaraherzog.bsky.social, @a-radzisheuskaya.bsky.social, @sankarinagarajan.bsky.social, @sebpreissl.bsky.social, @scherermich.bsky.social, and more! Check them out below!
flgenomics.bsky.social
How can cutting-edge tech help decode the complex #epigenome to reveal disease mechanisms, biomarkers & new therapies? Join us for the Unlocking the Epigenome: Precision Tools for Complex Diseases webinar series to find out. #epigenetics
Register now: hubs.la/Q03pFXJk0
Reposted by Michael Scherer
jorge-ferrer.bsky.social
Tracing human clones and lineages with DNA methylation. Congratulations for this fascinating breakthrough!
larsplus.bsky.social
Out @nature.com: Clonal tracing with somatic epimutations

🧬 Single cell methylome encodes cell state & clonal identity

🔨 EPI-Clone reads out both (+mutations, +RNA) at scale

🩸 Clonal expansions of HSCs are universal from age 50, not driven by CH mutations

doi.org/10.1038/s415...
🧵
Clonal tracing with somatic epimutations reveals dynamics of blood ageing - Nature
The discovery that DNA methylation of different CpG sites can serve as digital barcodes of clonal identity led to the development of EPI-Clone, an algorithm that enables single-cell lineage tracing th...
doi.org
Reposted by Michael Scherer
www.pcb.ub.edu
#PCBCommunity |🩸Un equip de l’ @irbbarcelona.org i el @crg.eu identifica “codis de barres” en el #ADN que revelen com envelleix la #sang.

🔬 La recerca publicada en @nature.com obre la porta a noves estratègies per la detecció de la #leucèmia mieloide i les malalties #cardiovasculars i immunitàries.
Investigadors de l'IRB Barcelona i del CRG identifiquen "codis de barres" escrits en el nostre ADN que revelen com envelleix la sang - Parc Científic de Barcelona
Identifiquen patrons de metilació naturals que desvelen canvis en la sang detectables a partir dels 50 anys i universals a partir dels 60.
www.pcb.ub.edu